GD Forensic analysis
Detailed research
# GENERAL DYNAMICS CORPORATION (GD) - TECHNO-FUNDAMENTAL ANALYSIS
GENERAL DYNAMICS CORPORATION (GD) - TECHNO-FUNDAMENTAL ANALYSIS
Analysis Date: September 1, 2026 | Current Price: $371.35
TRADING EXECUTION & ENTRY STRATEGY
Current Technical Setup - BEARISH MOMENTUM WITH OVERSOLD SIGNAL
Immediate Trading Context:
GD is trading at $371.35, down -2.29% in 1D, -3.37% in 5D, -3.15% in 20D. The stock has triggered a BEARISH_CROSSING pattern with RSI at 38.86 (approaching oversold territory at 30). The recent price action sits -1.96% below the 5-day SMA ($378.76) and -3.32% below the 10-day SMA ($384.11), but critically, it remains +4.90% above the 200-day SMA ($354.00), indicating support is intact despite short-term weakness.
MACD Signal: BEARISH with histogram at -2.8911, confirming downward momentum extension.
Key Levels:
- >Resistance: $384.11 (10-day SMA), $400.25 (Bollinger Band upper)
- >Support: $375.82 (50-day SMA), $354.00 (200-day SMA - critical long-term support)
RECOMMENDED TRADING SETUP: Cautious Pullback Bounce Strategy
Position Type: Swing Trade (2–5 Days) (Short-term bounce play on oversold conditions)
Position Sizing: 2-3% of portfolio
Entry Strategy (Scale In):
- >Initial Entry (30% of position): $368.00-$370.00 (Current pullback zone, slight bounce confirmation)
- >Add 40% at $375.82: 50-day SMA support level - technical confluence zone
- >Final 30% at $372.50: Mid-range pullback for averaging
Rationale: RSI at 38.86 is approaching oversold (RSI < 30 is extreme), suggesting contrarian bounce opportunity. However, do NOT assume this is a BUY signal - the fundamental thesis below indicates near-term headwinds. This is a tactical bounce trade, not a conviction long.
Take Profit Levels:
- >Sell 50% at $380.00: Quick mean-reversion target (1.0-1.5% rally)
- >Sell 30% at $385.00: 10-day SMA resistance
- >Trail 20% with stop at $377.50 for potential continuation if momentum breaks above $384
Stop Loss: $365.00 (Hard stop below recent pullback support, -1.7% risk)
Risk/Reward:
- >Risk: $6.35/share ($371.35 - $365.00)
- >Reward: $13.65/share (target avg $385 - entry avg $372)
- >R/R Ratio: 1:2.15 (Acceptable for swing trade)
Max Hold Time: 5 days or until RSI reverts above 50 (exit if momentum fails to extend)
Catalyst Timing: Trade should be EXITED before Q3 2026 earnings (likely late October). Do not hold through earnings given the fundamental softness identified below.
EXECUTIVE SUMMARY
General Dynamics is a $100B+ market-cap aerospace & defense leader with strong backlog ($136.5B) and stable government contracts, but faces near-term momentum challenges and valuation headwinds. Q2 2026 results (ended July 5, 2026) show solid fundamentals (+8% YoY revenue to $14.1B) but margin compression (-50bps operating margin). Recent price weakness reflects profit-taking from 2024-2025 rally and macro uncertainty (interest rates, defense spending priorities). Technical oversold conditions suggest tactical bounce opportunity, but conviction is LOW given bearish momentum crossover and lack of near-term catalysts. Rating: HOLD with tactical swing trade on pullback. 12-month outlook: Neutral at $385-395 fair value vs. street estimates of $410+.
RECENT MATERIAL EVENTS (8-K ANALYSIS)
No material 8-K filings identified in the data provided for the period immediately preceding the 10-Q filing (July 5, 2026). The 10-Q represents the most recent material disclosure. Key operating highlights from the Q2 results:
- >Backlog remains strong at $136.5B (flat vs. prior year, but healthy multiyear visibility)
- >Cash generation robust: $4.0B operating cash flow YTD (vs. $1.5B prior year) driven by customer advances of $1.2B - a positive sign of contract engagement but also reflects timing of milestone payments
- >Debt reduction: $500M repayment of maturing 2026 notes; total debt down to $7.5B from $8.1B
Key Risk: Large international tracked vehicle contract has $1.3B unbilled receivables with noted risk of lower-than-estimated variable consideration (contract modification risk).
INSIDER TRADING ACTIVITY
No recent Form 4 filings provided in the data. However, the 10-Q shows:
- >Share repurchases: Only 0.9M shares repurchased for $319M in H1 2026 (vs. 2.4M for $600M in H1 2025)
- >Dividend raised: Declared $3.18/share for H1 2026 (vs. $3.00 in H1 2025), +6% YoY - signals management confidence in cash generation
- >Equity compensation: $107M SBC expense YTD (vs. $89M prior year) - moderate dilution
Interpretation: Conservative share buyback activity and dividend increase suggest management is HOLD, not BUY on valuation. The slowing buyback pace is a WARN signal that management sees limited upside at current prices.
CURRENT NEWS & MARKET CONTEXT
No specific news items provided in the dataset for August-September 2026. However, the technical backdrop as of Sept 1, 2026, indicates:
- >Market-wide pullback: GD -3.37% in 5 days suggests sector rotation out of defense on broader macro concerns (likely Fed rate expectations, recession fears, or geopolitical de-escalation talk)
- >Defense spending still intact: Q2 results show DoD revenue $15.7B of $27.6B total (57% of revenue), unchanged YoY - no contract cancellations or stretch-outs apparent
- >No guidance change implied: Management updated no forward guidance in 10-Q, suggesting confidence in FY2026 trajectory
Sector Context: Expect defense stocks to be volatile ahead of potential Q4 policy changes (Defense budget approvals, geopolitical shifts).
BUSINESS MODEL ANALYSIS
Revenue Mix & Diversification
| Segment | H1 2026 Revenue | % of Total | Key Products | Contract Mix |
|---|---|---|---|---|
| Aerospace | $6.8B | 25% | Aircraft manufacturing ($4.8B), services ($2.0B) | 91% fixed-price, 9% time-and-materials |
| Marine Systems | $9.0B | 33% | Submarines ($6.8B), surface ships ($1.6B), repair ($0.6B) | 47% fixed-price, 53% cost-reimbursement |
| Combat Systems | $4.6B | 16% | Military vehicles ($2.3B), weapons/munitions ($1.6B), engineering ($0.7B) | 85% fixed-price, 14% cost-reimbursement |
| Technologies | $7.2B | 26% | IT services ($4.7B), C5ISR solutions ($2.5B) | 40% fixed-price, 42% cost-reimbursement, 18% T&M |
| Total | $27.6B | 100% | - | 62% fixed-price, 31% cost-reimbursement, 7% T&M |
Pricing Power Assessment:
- >Fixed-price contracts dominate (62%) - creates margin risk on inflation/cost overruns but allows higher margins on well-managed programs
- >Cost-reimbursement (31%) - provides margin stability and reduces customer concentration risk
- >Customer concentration: 57% DoD, 13% U.S. commercial (Aerospace), 30% non-U.S. - relatively diversified for defense contractor
Operating Margin Analysis
| Metric | Q2 2026 | Q2 2025 | YTD 2026 | YTD 2025 | Trend |
|---|---|---|---|---|---|
| Operating Margin | 10.35% | 10.01% | 10.44% | 10.18% | Flat to slightly up |
| Operating Earnings | $1,460M | $1,305M | $2,880M | $2,573M | +11% YoY |
| Revenue Growth | +8.1% | - | +9.1% | - | Solid growth |
Segment Operating Margins (H1 2026):
- >Aerospace: 14.7% (vs. 13.7% prior year) - improving (higher aircraft deliveries, services leverage)
- >Marine Systems: 7.3% (vs. 6.9% prior year) - improving (submarine production ramping, cost discipline)
- >Combat Systems: 13.7% (vs. 13.8% prior year) - flat (mix shift to lower-margin vehicles)
- >Technologies: 9.4% (vs. 9.6% prior year) - slight pressure (IT services labor inflation)
Assessment: Margins are healthy but NOT expanding significantly. Operating earnings growth of +11% is driven primarily by revenue growth (9%), not margin expansion. This suggests limited pricing power in a competitive bid environment.
FINANCIAL HEALTH ANALYSIS
Revenue Quality & Cash Conversion
| Metric | July 5, 2026 | Dec 31, 2025 | Commentary |
|---|---|---|---|
| Accounts Receivable | $2.4B | $2.4B | Flat - stable customer payment terms |
| Unbilled Receivables | $9.3B | $8.4B | +$875M (+10.4%) - work in progress growing faster than collections [WARN] |
| Days Sales Outstanding (DSO) | ~58 days | ~57 days | Lengthening slightly - billing/collection slowing |
| AR/Revenue Ratio | 17.3% of revenue | 18.9% | Improving - better near-term collections |
| Contract Liability (Advances) | $11.0B | $9.8B | +$1.2B (+12%) - strong customer prepayments, positive for cash |
[CRIT]: Unbilled receivables growth outpacing revenue growth suggests longer contract cycles or delay in billing milestones. This is NOT alarming for a defense contractor (normal for multi-year programs) but watch for deterioration in collection rates going forward.
Cash Flow Quality
| Metric | H1 2026 | H1 2025 | Δ |
|---|---|---|---|
| Operating Cash Flow | $4.0B | $1.5B | +169% |
| Free Cash Flow (OCF - CapEx) | $3.6B | $1.1B | +227% |
| CapEx as % of Revenue | 1.6% | 1.3% | +30bps (modest increase) |
| Cash Conversion Rate | 175% of net earnings | 72% | Exceptional |
Key Driver of OCF Surge:
- >Customer advances increased $1.2B - primary driver of H1 2026 cash surge
- >Unbilled receivables used $846M cash - headwind, partial offset
- >Working capital timing favorable in H1 but likely reverses in H2
[WARN]: The exceptional OCF improvement is heavily dependent on customer advance timing. If major milestones are skipped in H2, cash flow will normalize/decline. Not sustainable at $4B per half.
Balance Sheet Strength
| Metric | July 5, 2026 | Dec 31, 2025 | Assessment |
|---|---|---|---|
| Total Assets | $60.2B | $57.2B | Growing, driven by contract assets (unbilled) |
| Total Debt | $7.5B | $8.1B | Declining - good deleveraging |
| Cash | $4.3B | $2.3B | +$2.0B - strong cash position |
| Net Debt | $3.2B | $5.8B | $2.6B improvement - net debt declining |
| Shareholders' Equity | $26.8B | $25.6B | +$1.2B - healthy capital base |
| Debt/EBITDA | ~0.8x | ~0.95x | Very conservative |
| Interest Coverage | ~12x (est.) | ~12x | Strong - no refinance risk |
Assessment: Balance sheet is fortress-like with low leverage, strong cash generation, and declining net debt. No financial distress risk whatsoever. However, leverage is conservatively managed - management is prioritizing debt reduction and dividends over growth investments or M&A, suggesting cautious outlook on growth.
Goodwill & Intangibles
- >Goodwill: $20.9B (down $82M) - stable, no impairments
- >Intangible Assets: $1.3B (down $94M) - amortizing normally
- >Goodwill as % of Equity: 78% - [WARN] - material intangible asset base means valuation is NOT backed by tangible assets
- >Technologies segment: $14.5B goodwill (70% of total) - reflects past M&A in IT/C5ISR; risk if contracts decline
VALUATION ANALYSIS
Current Valuation Multiples
| Metric | Current | TTM Basis | Assessment |
|---|---|---|---|
| Stock Price | $371.35 | - | - |
| Shares Outstanding | 270.6M | - | - |
| Market Cap | $100.5B | - | - |
| EPS (Diluted, YTD) | $8.35 | ~$16-17 (est.) | Based on H1 $8.35, implied FY ~$16.70-17.00 |
| P/E Ratio | 22.2x (using $16.70 est. EPS) | 22.2x | EXPENSIVE vs. historical 18-20x |
| EV (Debt - Cash) | $99.2B | - | - |
| EV/Revenue | 3.6x (based on FY 2026E $27.5B) | 3.6x | High - typically 3.0-3.3x for defense |
| EV/EBITDA | 12.5x (est. EBITDA $7.9B) | 12.5x | At upper end of range (11-13x) |
Reverse DCF - Implied Growth Rate
Assuming:
- >Current Price: $371.35
- >Implied WACC: 6.5% (risk-free 4.5% + defense equity risk premium 2.0%)
- >Terminal Growth Rate: 2.5% (GDP growth + modest defense spending growth)
- >FCF Yield Target: 3.5% (normalized, vs. current ~3.8% driven by working capital)
Implied Calculation: For P/E of 22.2x with ~$17 EPS:
- >Required Annual Growth: ~7-8% CAGR over next 5 years
- >Market is pricing in: Mid-single-digit revenue growth + 30-50bps margin expansion
- >Current trajectory: GD delivering ~9% revenue growth + flat margins
Verdict: Stock is trading at a premium to intrinsic value assuming:
- >Margins do NOT expand materially (currently flat)
- >Revenue growth moderates to 5-6% by 2028 (from current 9%)
- >Backlog doesn't materially improve (already large at $136.5B)
Price Target Analysis
Bull Case ($410-430):
- >Margins expand 50-75bps on operational leverage (aerospace, submarine ramp)
- >Revenue growth sustains at 7-8% through 2027
- >Multiples remain at 22-23x P/E on stable WACC
- >Upside: +10-16% from $371
Base Case ($380-395):
- >Margins flat at 10.4%
- >Revenue growth moderates to 5-6% post-2026
- >Multiples contract to 20-21x P/E as interest rates remain elevated
- >Upside/Downside: -3 to +6% from $371
Bear Case ($340-360):
- >Margins compress 50-75bps due to fixed-price contract mix and labor inflation
- >Revenue growth slows to 3-4% on defense budget constraints
- >Multiples re-rate to 18-19x P/E (historical low) on recession fears
- >Downside: -8 to -13% from $371
COMPETITIVE POSITION
Market Position: GD is #3 U.S. aerospace & defense contractor by revenue (behind Lockheed Martin and Boeing, excluding commercial aerospace).
Competitive Advantages:
- >Diversified portfolio: 4 segments with limited overlap reduces single-program risk
- >Government relationships: DoD prime contractor across land, sea, air domains
- >Technology depth: C5ISR and IT services provide secular growth tailwinds vs. legacy platforms
- >Backlog visibility: $136.5B backlog (5+ year revenue visibility) is industry-leading
Competitive Weaknesses:
- >Scale disadvantage: LMT ($60B+ revenue) and RTX ($70B+ revenue) have greater economies of scale
- >Technology commoditization: IT/C5ISR services increasingly commoditized; pricing power declining
- >Fixed-price exposure: 62% of backlog is fixed-price, creating margin pressure in inflationary environment
- >International exposure risk: 30% revenue outside U.S., with Combat Systems exposure to large international tracked vehicle contract (noted contract modification risk)
Outlook: GD maintains stable competitive position but faces incremental margin pressure from mix shifts and labor cost inflation. Not losing share, but not gaining share either.
MANAGEMENT QUALITY
Strengths:
- >Consistent execution: Margins stable, backlog growing, cash conversion improving
- >Capital allocation: Balanced approach of debt reduction, dividend increases, and modest buybacks
- >Transparency: Detailed segment disclosure and risk management (e.g., international contract disclosures)
Concerns:
- >Conservative posture: Slowing buybacks (0.9M shares in H1 2026 vs. 2.4M in H1 2025) suggests management sees limited upside at current valuations
- >M&A absent: No material acquisitions in recent years despite strong cash generation - suggests limited growth acquisition targets at reasonable prices
- >Dividend growth modest: +6% YoY increase in dividend modest vs. earnings growth, suggesting management prioritizing balance sheet over shareholder returns
Assessment: Professional, competent management team executing a mature, low-growth business model. Not aggressive growth, but solid stewards of capital.
RISK FACTORS
[CRIT] - Critical Risks
- >
Defense Budget Uncertainty: 60% of revenue from DoD; any significant budget reduction would directly impact backlog conversions and future orders. Congressional deadlock on defense appropriations could delay program starts.
- >
Fixed-Price Contract Risk: 62% of backlog is fixed-price. Major contract overruns on submarines or military vehicles could materially compress margins. Noted risk on international tracked vehicle contract with $1.3B unbilled receivables.
- >
Inflationary Cost Pressure: Labor inflation (especially in skilled engineering roles) and material costs could pressure fixed-price margins. No evidence of sufficient contract price escalators to offset full inflation impact.
[WARN] - Material Risks
- >
Geopolitical De-escalation: If major international conflicts resolve (e.g., Ukraine, Middle East), defense spending could normalize downward, reducing GD's growth trajectory. Combat Systems segment most exposed (22% of revenue from non-U.S. government).
- >
Technology Disruption: Autonomous systems, AI, cyber capabilities could shift spending away from legacy platforms (submarines, military vehicles) toward next-gen systems where GD may lack competitive advantage.
- >
Supply Chain Fragility: Defense industrial base remains constrained post-COVID. GD's backlog execution heavily dependent on supplier availability and pricing.
- >
Valuation Multiple Compression: Trading at 22x P/E vs. historical 18-20x. Rising interest rates could compress defense multiples as equity investors rotate to higher-yielding assets.
[WARN] - Operational Risks
- >
Unbilled Receivables Deterioration: $9.3B unbilled receivables growing faster than revenue. If billing milestones slip or customers dispute change orders, cash conversion could deteriorate.
- >
Technologies Segment Concentration: 35% of revenue from IT/C5ISR services which face commoditization and pricing pressure. Growth in this segment flagging (only +4.2% YoY in H1).
- >
Aerospace Cycle Risk: Business jet demand cyclical. Q2 aircraft manufacturing revenue up 16% YoY but backlogs could normalize if economic growth decelerates.
FORENSIC ACCOUNTING FLAGS
[CRIT] Red Flags
- >
Contract Estimate Adjustments Material to EPS: H1 2026 contract estimate adjustments added $0.24 to diluted EPS (2.9% of total). This is material. In Q2 alone, $0.08 of EPS came from contract true-ups. This suggests earnings quality is moderate - results depend on management's contract estimate accuracy, not just operational performance. Monitor quarterly adjustments closely.
- >
Large International Contract Risk Disclosed: Management notes $1.3B unbilled receivables on a large international tracked vehicle contract in Combat Systems with risk of lower variable consideration than estimated. This is a known risk that could materially impact future earnings if contract estimates are revised downward. [CRIT] This is a potential earnings revision bomb if the customer disputes pricing.
[WARN] Yellow Flags
- >
Unbilled Receivables Growing Faster Than Revenue:
- >H1 2026 unbilled receivables: $9.3B (+10.4% vs. Dec 2025)
- >H1 2026 revenue: $27.6B (+9.1% YoY)
- >Unbilled/Revenue ratio: 33.6% (vs. 33.2% prior year)
- >Implication: Work in progress is accumulating slightly faster than being billed. This is not alarming in defense (normal for multi-year programs) but watch for acceleration. If this ratio exceeds 35%, it signals potential billing delays or customer disputes.
- >
Days Sales Outstanding Lengthening:
- >Accounts Receivable: $2.4B (stable)
- >Estimated quarterly revenue: $14.1B
- >Implied DSO: ~50 days (vs. ~45 days historically)
- >Trend: Lengthening collection cycles, though still reasonable for defense.
- >
Equity-Based Compensation Creeping:
- >H1 2026 SBC: $107M (+20% vs. H1 2025 $89M)
- >As % of operating earnings: 3.7%
- >Assessment: Not excessive, but growing faster than revenue. Typical for tech-heavy defense, but watch for further acceleration.
- >
Goodwill Concentration in Technologies:
- >Technologies segment: $14.5B of $20.9B goodwill (69%)
- >Technologies segment operating margin: 9.4% (lowest of all segments)
- >Risk: If Technologies segment falters, goodwill impairment risk emerges. Currently no impairment, but accumulated impairments of $1.8B noted in filing suggest past acquisition challenges in this segment.
[WARN] Green Flags (Positive Signs)
- >
Revenue Quality Strong:
- >75% of revenue recognized over time (work-in-progress, not point-in-time sales)
- >Minimal revenue adjustment volatility (largest adjustment $78M in Q2, 0.6% of revenue)
- >Assessment: Revenue is NOT aggressive. Earnings quality is reasonable.
- >
Cash Flow Conversion Solid:
- >H1 2026 operating cash flow: $4.0B (175% of net earnings)
- >While inflated by customer advance timing, underlying operational conversion is healthy
- >Free cash flow positive and growing
- >
Debt Quality Strong:
- >All fixed-rate debt, average maturity ~7 years
- >No material refinance risk through 2027
- >Credit facility $4B and shelf registration provide liquidity
TECHNICAL ANALYSIS & TRADE TIMING
Current Technical Setup (As of Sept 1, 2026)
Price Action:
- >Current Price: $371.35
- >1D Change: -2.29% (intraday weakness)
- >5D Change: -3.37% (pullback from recent highs)
- >20D Change: -3.15% (mild downtrend in progress)
Moving Averages & Trend:
- >5-Day SMA: $378.76 (Price is -1.96% below)
- >10-Day SMA: $384.11 (Price is -3.32% below)
- >50-Day SMA: $375.82 (Price is -1.19% below) - CRITICAL SUPPORT LEVEL
- >200-Day SMA: $354.00 (Price is +4.90% above) - LONG-TERM SUPPORT INTACT
- >Trend Status: BEARISH_CROSSING (short-term downtrend, but long-term uptrend not yet broken)
Momentum Indicators:
- >RSI (14-day): 38.86 - APPROACHING OVERSOLD (RSI < 30 is oversold, RSI > 70 is overbought)
- >Interpretation: Stock has sold off sharply but NOT yet reached panic levels
- >Contrarian signal: Bounce opportunity exists if selling exhausts
- >MACD: BEARISH with histogram -2.8911
- >Interpretation: Downward momentum is still extending, not yet reversing
- >Concern: MACD has NOT yet crossed above signal line, so bounce is NOT confirmed yet
Bollinger Bands:
- >Upper Band: $400.25 (Resistance, +7.8% upside to band)
- >Current Price: $371.35 (Within band)
- >Lower Band: $374.06 (Support, close to current price)
- >Interpretation: Stock is trading in the lower half of the band, suggesting room for mean reversion bounce but not yet stretched to lower band extremes
Technical Reconciliation with Fundamentals
The Widowmaker Rule Applied:
- >Fundamentals Say: HOLD to NEUTRAL (solid backlog, decent margins, but valuation stretched at 22x P/E)
- >Technicals Say: OVERSOLD with BEARISH momentum (RSI approaching 30, MACD negative)
- >Reconciliation: This is NOT a short opportunity even though technicals are weak. The issue is that GD is not overvalued on fundamentals (fair value $380-395), so shorting into a potential bounce is risky. Instead, wait for confirmed breakdown below $354 (200-day SMA) before initiating shorts. Currently, any bounce is a sell opportunity on strength, not a buy opportunity.
The Value Trap Rule Applied:
- >Fundamentals: Not a value trap (company is executing, not deteriorating)
- >Technicals: BEARISH_CROSSING (price breaking below key moving averages)
- >Verdict: This is NOT a classic value trap, but the combination of expensive valuation (22x P/E) + deteriorating technicals = CAUTION flag. Do NOT assume every dip is a buy.
Key Technical Levels to Watch
| Level | Type | Significance |
|---|---|---|
| $384.11 | Resistance | 10-day SMA; if broken to upside, could signal momentum reversal |
| $378.76 | Resistance | 5-day SMA; initial resistance zone on any bounce |
| $375.82 | Support | 50-day SMA; KEY SUPPORT - close watch if broken |
| $354.00 | Support | 200-day SMA; CRITICAL SUPPORT - long-term trend reversal if broken |
| $400.25 | Resistance | Bollinger Band upper; previous consolidation high |
Price Prediction Framework
Next 5 Trading Days (Sept 1-9, 2026):
- >
Most Likely Scenario (60% probability): Bounce to $378-385 on oversold conditions, then fade back to $370-375
- >Catalyst: Oversold technical setup, upcoming potential Fed decision or economic data
- >Conviction: MEDIUM - dependent on RSI bouncing above 40 and MACD stabilizing
- >
Bull Scenario (20% probability): Clean break above $385, retest of $395-400 if momentum confirms
- >Catalyst: Positive defense spending announcement, earnings beat, or macro relief (Fed pivot)
- >Conviction: LOW - would require external catalyst not yet visible
- >
Bear Scenario (20% probability): Break below $375, test of $354 if selling accelerates
- >Catalyst: Recession fears, defense budget cuts, earnings miss in Q3
- >Conviction: LOW - current setup does NOT yet signal capitulation
SHORT-TERM TRADING STRATEGY (2-5 DAYS)
Recommended Timeframe: Swing Trade (2–5 Days) (Do NOT hold through earnings or major macro events)
Position Sizing: 2-3% of portfolio (modest position for swing trade)
Scaling Strategy
Phase 1 - Initial Entry (30% of position):
- >Entry Zone: $368.00 - $370.00 (current pullback support)
- >Reasoning:
- >Stock has pulled back 3.4% in 5 days and RSI is at 38.86 (near oversold)
- >Bounce trades typically initiate when RSI crosses above 35 and price holds above recent support
- >Entry at current levels provides 1:2 risk/reward potential if resistance at $378-380 holds
- >Entry Trigger: Confirm with positive day (close above open) or bouncing RSI > 40 on intraday bounce
- >Position Size: 30% (e.g., if trading 3% portfolio position, allocate 0.9% here)
Phase 2 - Add on Support (40% of position):
- >Add at: $375.82 (50-day SMA, confluence with technical support)
- >Reasoning:
- >If initial entry holds and stock bounces, adding at 50-day SMA creates lower average entry
- >50-day SMA is key intermediate-term support; break below would invalidate entire thesis
- >This level also represents a decision point: If stock bounces off $375.82, momentum is recovering; if it breaks below, trade is terminated
- >Position Size: +40% (cumulative position now 70%)
- >Condition: ONLY add if stock bounces from $370, not if it continues to sell off below $370
Phase 3 - Final Entry (30% of position):
- >Entry at: $372.50 (midpoint between $370-$375)
- >Reasoning:
- >Opportunistic fill on any additional intraday weakness
- >Creates higher average entry for a 3-phase scale-in, but provides full position exposure
- >This is the final add level - if stock breaks below $375.82, exit the trade entirely
- >Position Size: +30% (cumulative position now 100%)
- >Condition: Only if stock remains above $375 support
Take Profit Levels
Tier 1 - Quick Scalp (50% of position):
- >Target: $380.00 (mean reversion to 5-day SMA area)
- >Trigger: Stock bounces to $380 within 1-2 days
- >Reasoning:
- >Quick 2-3% gain on bounce trade
- >Exit 50% to lock in gains and reduce risk
- >Typical bounce amplitude from oversold RSI 38 is 2-4%, so $378-382 is realistic target
- >Exit Condition: Hard exit at market when price reaches $379.50-$380.50
Tier 2 - Intermediate Target (30% of position):
- >Target: $385.00 (resistance at 10-day SMA and recent consolidation high)
- >Trigger: If stock bounces through $380 with volume and momentum confirms
- >Reasoning:
- >10-day SMA at $384.11 acts as intermediate resistance
- >If stock sustains above this level with RSI > 50, could extend further
- >Exit 30% at this resistance to capture additional gains
- >Exit Condition: Sell 30% when price approaches $384-$386 zone, or if RSI diverges negatively
Tier 3 - Momentum Play (20% of position):
- >Target: Let run with trailing stop at $377.50
- >Reasoning:
- >If bounce gains momentum and breaks above $385, trend could extend to $390-$395
- >This is a low-conviction continuation but trades are sized to accommodate it
- >Trailing stop at $377.50 (below 50-day SMA) protects downside
- >Exit Condition:
- >Profit: Sell if price reaches $390-$395, or if technical overbought signals emerge (RSI > 65)
- >Loss: Hit trailing stop at $377.50 (2.3% loss on this tier only)
Stop Loss Strategy
Hard Stop Loss:
- >Price Level: $365.00 (below recent 5-day support cluster)
- >Reason:
- >Provides $6.35 per share loss buffer (1.7% from initial entry)
- >Breaks should occur if fundamentals deteriorate or macro event triggers selling
- >Below $365, technical breakdown is confirmed and trade invalidates
- >Order Type: GTC (Good-Till-Canceled) order at $365.00 or trail-stop-loss
Tactical Exit Rules (before hitting hard stop):
- >Exit full position if stock breaks below $375.82 (50-day SMA) decisively (close below, not just intraday touch)
- >Exit if RSI drops below 30 (panic selling) - suggests capitulation may extend further
- >Exit if MACD histogram crosses further negative (momentum failing) - suggests bounce attempt failed
Risk/Reward Calculation
Base Case Scenario:
- >Average Entry Price: ~$372 (blended across 3 entries: 30% @ $369, 40% @ $375.82, 30% @ $372.50)
- >Tier 1 Exit (50%): Sell at $380, gain $8.00/share × 50% position = $4.00 average gain
- >Tier 2 Exit (30%): Sell at $385, gain $13.00/share × 30% position = $3.90 average gain
- >Tier 3 Trail (20%):
- >Bull case: Sell at $395, gain $23.00/share × 20% = $4.60 average gain
- >Bear case: Stop out at $377.50, loss $5.50/share × 20% = -$1.10 average loss
- >Net Expected Gain (Bull Case): ($4.00 + $3.90 + $4.60 - $1.10 weighted) ≈ $10.50 total, or ~$2.80/share blended = 0.75% return on $372 entry
Risk Calculation:
- >Entry Cost: $372 average
- >Hard Stop: $365.00
- >Risk per Share: $7.00
- >Position Size: 3% of portfolio (e.g., $30K on $1M account)
- >Max Loss on Position: 3% × $7/$372 = -0.56% portfolio loss if stopped out
Risk/Reward Ratio:
- >Risk: -0.56% portfolio loss (hard stop hit)
- >Reward: +0.75% portfolio gain (base case exit at Tier 2/Tier 3)
- >Ratio: 1:1.34 (modest, but acceptable for 2-5 day swing trade)
Trade Timing & Catalyst Windows
Optimal Entry Window: Sept 2-4, 2026 (Next 1-3 trading days)
- >Rationale: RSI at 38.86 is primed for bounce; enter early to capture first leg up
- >Avoid holding into Q3 earnings (likely late October 2026)
Exit Window: Sept 4-8, 2026 (Target 2-5 day hold)
- >Rationale: Expected bounce amplitude is 2-4%, which would be achieved in 2-5 days
- >If bounce fails and stock breaks below $375 by Sept 4, cut losses and exit
Earnings Blackout: DO NOT hold any portion of this position into Q3 earnings (late October). Exit all positions by Sept 15 latest, regardless of profit/loss, to avoid earnings surprise risk.
INVESTMENT RECOMMENDATION
Overall Rating: HOLD (Conviction: 6/10)
Summary Thesis: General Dynamics is a high-quality, well-managed defense contractor with strong backlog visibility, solid cash generation, and fortress-like balance sheet. However, the stock is fairly valued at best, expensive at worst (22x P/E vs. historical 18-20x), trading at a premium to intrinsic value assuming flat margins and moderating growth. Recent technical weakness (RSI 38.86, BEARISH momentum) presents a tactical swing trading opportunity for patient traders, but core position should remain HOLD, not accumulate. Near-term upside is limited (~5-8% to fair value of $385-395), while downside risks include contract estimate revisions on international tracked vehicle program and margin compression from fixed-price contract inflation exposure. Best action: Wait for pullback to $365-370 before initiating new positions, or trade existing bounces with strict 2-5 day holding periods.
12-Month Price Targets
| Scenario | Price Target | Probability | Drivers |
|---|---|---|---|
| Bull Case | $410-430 | 25% | Margin expansion from operational leverage; sustained 7%+ revenue growth; DoD spending stability |
| Base Case | $380-395 | 55% | Flat margins; 5-6% revenue growth; multiples stay flat; no major catalysts |
| Bear Case | $340-360 | 20% | Margin compression; defense budget cuts; valuation re-rating to 18-19x; economic slowdown |
Base Case Fair Value: $390 (using 21x P/E × $18.50 estimated 2027 EPS)
ONE-LINER THESIS
GD is a solid cash-generative defense franchise at a HOLD valuation - quality business, stretched price, wait for pullback or tactical bounces only, no conviction to buy here.